Please login to the form below

Not currently logged in
Email:
Password:

INC Research expands into Japan

CRO strengthens its APAC capabilities with Osaka and Tokyo offices

Contract research organisation (CRO) INC Research has expanded its Asia Pacific operations with the opening of two new centres in Japan.

Located in Tokyo and Osaka, INC Research Japan KK will initially be run by a core of English-speaking management, regulatory and therapeutic staff, with the intention of aligning the company's 'Trusted Process' outsourcing methodologies with traditional Japanese clinical research practices.

The move means INC Research now has 20 offices across the Asia Pacific region, including in China, India, Singapore, Australia, New Zealand, Philippines, South Korea, Hong Kong and Taiwan.

“There is a growing enthusiasm from both pharma and government sectors for Japan to be involved in both global and regional clinical trials,” explained Garth Tierney, executive VP, Asia/Pacific.

“In response, INC Research is implementing a very considered approach to the market that will create greater confidence among our customers in conducting trials in Japan, as well as ultimately provide more direct influence on how trials are conducted.

“Our Japanese customers already have responded positively to our Trusted Process methodology as it fits well with their requirements for high quality and predictability. We are very enthusiastic about bringing the continued benefits of drug development in this country to our customers.”

Prior to establishing its own business operations in the country, INC Research has partnered with local Japanese CROs in order to conduct trials across a variety of therapeutic areas.

2nd August 2013

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...
#DemandDiversity: Black history in clinical trials: It's more than just Tuskegee [Infographic]
Take a look at this infographic showing some of the most notorious clinical trials and medical research in history....
Looking back at the year when everything changed
COVID-19 has impacted every aspect of our lives, from the way we shop for groceries to the way we conduct work and interact with healthcare providers and our families....

Infographics